Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Galderma apresenta novas abordagens para o uso do bioestimulador de colágeno e ácido hialurônico em procedimentos estéticos


News provided by

Galderma

Oct 17, 2022, 13:43 ET

Share this article

Share toX

Share this article

Share toX

Durante o maior evento privado de estética do mundo, a Galderma, líder do mercado de estética1, lança abordagens de aplicação de seus produtos Sculptra® e Restylane®, considerados top of mind entre profissionais da saúde injetores*2

SÃO PAULO, 17 de outubro de 2022 /PRNewswire/ -- No último fim de semana, ocorreu em São Paulo a 6ª edição do maior evento privado de estética do mundo, denominado MAP (Managing Aesthetic Patients). Realizado pela indústria farmacêutica Galderma, especialista em dermatologia, o evento contou com a presença – online e presencial- de mais de 9 mil médicos.

Continue Reading

Durante a ocasião, voltada para apresentar novas soluções da marca e aprimorar o conhecimento científico desses profissionais sobre procedimentos estéticos pouco invasivos, a Galderma trouxe novas abordagens de aplicação de seu bioestimulador de colágeno Sculptra® e de seu portfólio de ácido hialurônico injetável Restylane®.

"Nessa 6ª edição, demonstramos novamente o nosso compromisso com a ciência, adaptada à realidade dos pacientes e médicos. Mais uma vez histórico, o MAP apresentou novas abordagens que visam recuperar a qualidade geral da pele, evidenciando a versatilidade de nossos produtos que podem ser combinados e manejados de acordo com a individualidade de cada paciente", comenta Lígia Santos, Head da unidade de negócios de estética da Galderma para Brasil e América Latina.

Durante os dois dias de evento, foram apresentados conceitos e técnicas como Firm&Up Abs, Shape Up, Bright Eyes, Kiss&Smile e Perfil 3D, que utilizam Sculptra® e Restylane®. A técnica Firm&Up Abs consiste na aplicação de Sculptra® na região abdominal, enquanto a Shape Up aborda Sculptra® na região da face. Já os conceitos Bright Eyes, Kiss&Smile e Perfil 3D utilizam a aplicação do mais completo³ e seguro4 portfólio de ácido hialurônico injetável, Restylane®, e, em alguns casos, a combinação entre Sculptra® e Restylane®.

A técnica Firm&Up Abs, tem como objetivo ajudar a restaurar a firmeza da pele do abdômen, proporcionando um efeito de "cola" da pele no músculo e amenizar alguns incômodos que a flacidez provoca na região, como o "umbigo triste". "O bioestimulador de colágeno, apesar de ser mais conhecido pelo seu uso na face, tem excelentes resultados no corpo. Além do abdômen e glúteos, ele pode ser aplicado no pescoço, colo, braços, coxas e joelhos5,6. O mais legal dessa substância é que ela estimula a própria pele a produzir mais colágeno e seus resultados podem durar até 25 meses7", comenta o dermatologista Dr. Daniel Coimbra (CRM-RJ 775754).

Já a abordagem Shape Up mostrou as várias formas de aplicar o bioestimulador de colágeno Sculptra® em pacientes diversos entre si, mas com uma coisa em comum: a necessidade de repor colágeno. "Para cada história de pele, uma região de aplicação diferente. Assim, ao personalizarmos a aplicação do bioestimulador de colágeno na face, de acordo com as características individuais de cada paciente, endereçamos a solução para a perda natural de colágeno que sofremos ao longo dos anos e restauramos a sustentação e qualidade da pele dos nossos pacientes" explica o cirurgião plástico e Head da área de educação médica da Galderma Brasil, Dr. Fabio Saito (CRM- SP 97388).

Sculptra®, presente há 18 anos no mercado brasileiro, é o bioestimulador de colágeno com maior segurança e eficácia na opinião dos especialistas8, e o único bioestimulador de colágeno capaz de aumentar a produção dessa proteína em 66,5%**9.

A Galderma traz também novas abordagens de aplicação do portfólio de ácido hialurônico injetável Restylane® e as possibilidades de combinação dessa substância com Sculptra®. As abordagens Bright Eyes, Perfil 3D e Kiss&Smile, discutem, respectivamente, o tratamento da região dos olhos; da face, para melhorar o aspecto geral do perfil dos pacientes: definição do contorno facial, melhora do aspecto da testa, nariz, queixo e mandíbula; e da melhora do sorriso.

"Quando pensamos na necessidade de cada paciente, sempre tem algumas áreas que chamam mais atenção, seja um olhar de cansaço, uma perda de estruturação da face ou até um incômodo com o formato de seu sorriso. O que muitos pacientes ainda não compreendem é que, por muitas vezes, não tem como tratar apenas uma área para obter o resultado desejado. Foi pensando nisso, que criamos as abordagens Bright Eyes, Perfil 3D e Kiss&Smile", esclarece Dr. Fabio Saito.

Saito ainda esclarece que a abordagem Bright Eyes, por exemplo, não se concentra apenas em amenizar olheiras. São utilizados diversos géis de ácido hialurônico do portfólio Restylane® para tratar a região como um todo (têmporas, maçãs da face e testa). O mesmo acontece nas técnicas Perfil 3D e Kiss&Smile. A Perfil 3D visa tratar diferentes regiões da face, como queixo, mandíbula, testa e nariz, a fim de definir o contorno facial e proporcionar efeito lifting. Já a Kiss&Smile não é apenas o preenchimento labial. Essa técnica refere-se ao tratamento, quando necessário, da estrutura do rosto que pode afetar também o sorriso e os lábios.

Sculptra® e Restylane® são produtos utilizados em procedimentos estéticos pouco invasivos, que devem ser realizados por profissionais da saúde habilitados à prática de procedimentos estéticos injetáveis.

Os detalhes sobre o evento ainda podem ser conferidos no site e LinkedIn da Galderma.

*Top of Mind na categoria bioestimuladores de colágeno e ácido hialurônico injetável.

**Colágeno tipo l.

1Painel de Harmonização IQVIA - Informantes Galderma, Allergan + USK, Merz e Mosha8 - Universo de Injetáveis Estéticos (Exclusão de Injetaveis Terapêuticos).

2Pesquisa realizada pelo segundo ano consecutivo, 2021(n=141) e 2022 (n=150)

3Rzany B., Bayerl C., Bodokh I. et al. Eficacy and safety of a new hyaluronic acid dermal  filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 2011;13:107-112

4Artzi O, Loizides C, Verner I et al. Resistant and recurrent late reaction to hyaluronic acid–based gel. Dermatol Surg 2016;42:31–37

5Haddad A, Menezes A, Guarnieri C, et al. Recommendations on the Use of Injectable Poly-L-Lactic Acid for Skin Laxity in Off-Face Areas. J Drugs Dermatol. 2019;18(9):929-935.

6Kollipara R, Hoss E, Boen M, Alhaddad M, Fabi SG. A Randomized, Split-Body, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Poly-L-lactic Acid for the Treatment of Upper Knee Skin Laxity. Dermatol Surg. 2020 Dec;46(12):1623-1627.

7Narins R, Baumann L, Brandt F et al. A randomized study of the efficacy and safety of Injectable poly-l-lactic acid versus human–based collagen implant in the treatment. J Am Acad Dermatol. 2010 Mar;62(3):448-62

8Data on File. JOB 0507F20 Message Recall Aesthetics w1. HSR Health. Maio 2021.

9Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-922.

Sobre a Galderma
A Galderma é a maior empresa independente de dermatologia do mundo, presente em aproximadamente 100 países. Desde a sua criação em 1981, tem sido movida por uma dedicação completa à Dermatologia, oferecendo um portfólio inovador e com base científica de marcas e serviços sofisticados em Estética, Produtos ao Consumidor e Medicamentos. Focada nas necessidades dos consumidores e pacientes, a Galderma trabalha em parceria com profissionais de saúde para garantir resultados superiores. As marcas de estética da Galderma foram consideradas, pelo segundo ano consecutivo, top of mind dos profissionais da saúde nas categorias Bioestimuladores de Colágeno e Ácido Hialurônico, segundo pesquisa realizada em 2022. A empresa segue avançando a dermatologia para cada história de pele, porque entende que a pele em que estamos molda nossas histórias de vida. Para   mais informações, visite https://www.galdermaaesthetics.com.br/

Foto - https://mma.prnewswire.com/media/1922857/L9A2139_2.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.